Holdings of F/m Emerald Life Sciences Innovation ETF
ISIN US74933W2219
RBB Fund, Inc. · Original filing · Compare with another fund · Report an error
- Net assets
- 95.7M $ including 95.7M $ in equities, 100.0 %
- Positions
- 39 in 2 countries
- Top ten
- 52.5 % of net assets
- Filed on
- Feb 28, 2026
Portfolio shape
Positions
| Rank | Company | Shares | Value | Weight |
|---|---|---|---|---|
| 1 | Cogent Biosciences Inc | 222,753 | 8.7M $ | 9.05 % |
| 2 | LivaNova PLC | 99,696 | 7M $ | 7.36 % |
| 3 | TransMedics Group Inc | 34,639 | 5M $ | 5.26 % |
| 4 | Mirum Pharmaceuticals Inc | 50,148 | 4.6M $ | 4.84 % |
| 5 | Travere Therapeutics Inc | 148,543 | 4.4M $ | 4.63 % |
| 6 | Spyre Therapeutics Inc | 97,976 | 4.2M $ | 4.41 % |
| 7 | United Therapeutics Corp | 8,260 | 4.2M $ | 4.35 % |
| 8 | Guardant Health Inc | 44,027 | 4.1M $ | 4.32 % |
| 9 | WaVe Life Sciences Ltd | 288,933 | 4M $ | 4.21 % |
| 10 | Savara Inc | 641,260 | 3.9M $ | 4.04 % |
| 11 | KalVista Pharmaceuticals Inc | 223,591 | 3.6M $ | 3.81 % |
| 12 | Nektar Therapeutics | 50,114 | 3.5M $ | 3.61 % |
| 13 | ICU Medical Inc | 19,228 | 2.9M $ | 3.03 % |
| 14 | Trevi Therapeutics Inc | 228,121 | 2.7M $ | 2.84 % |
| 15 | Bridgebio Pharma Inc | 36,868 | 2.5M $ | 2.56 % |
| 16 | ACADIA Pharmaceuticals Inc | 95,052 | 2.3M $ | 2.44 % |
| 17 | Integer Holdings Corp | 24,094 | 2.1M $ | 2.18 % |
| 18 | Axsome Therapeutics Inc | 12,536 | 2.1M $ | 2.15 % |
| 19 | Collegium Pharmaceutical Inc | 47,276 | 2M $ | 2.06 % |
| 20 | Madrigal Pharmaceuticals Inc | 3,894 | 1.7M $ | 1.76 % |
| 21 | Ceribell Inc | 87,031 | 1.6M $ | 1.70 % |
| 22 | Globus Medical Inc | 16,017 | 1.5M $ | 1.60 % |
| 23 | Corcept Therapeutics Inc | 40,595 | 1.4M $ | 1.52 % |
| 24 | Waystar Holding Corp | 54,333 | 1.4M $ | 1.46 % |
| 25 | Lumexa Imaging Holdings Inc | 93,554 | 1.3M $ | 1.38 % |
| 26 | Cytokinetics Inc | 21,236 | 1.3M $ | 1.38 % |
| 27 | Billiontoone Inc | 16,657 | 1.3M $ | 1.33 % |
| 28 | Xeris Biopharma Holdings Inc | 204,432 | 1.3M $ | 1.31 % |
| 29 | Alphatec Holdings Inc | 76,228 | 1M $ | 1.09 % |
| 30 | RadNet Inc | 14,680 | 1M $ | 1.07 % |
| 31 | Hinge Health Inc | 23,847 | 1M $ | 1.07 % |
| 32 | Soleno Therapeutics Inc | 26,025 | 1M $ | 1.06 % |
| 33 | Corvus Pharmaceuticals Inc | 52,479 | 958.3K $ | 1.00 % |
| 34 | Insmed Inc | 5,962 | 890.3K $ | 0.93 % |
| 35 | Aveanna Healthcare Holdings Inc | 104,190 | 766.8K $ | 0.80 % |
| 36 | Korro Bio Inc | 61,915 | 751K $ | 0.79 % |
| 37 | F/m US Treasury 6 Month Bill E | 12,655 | 633.3K $ | 0.66 % |
| 38 | F/m Ultrashort Treasury Inflat | 10,720 | 533.3K $ | 0.56 % |
| 39 | NeoGenomics Inc | 42,429 | 417.1K $ | 0.44 % |
Sector breakdown
- Health care 5.3 %
- Unattributed 94.7 %
Titelia classification, company by company. The unattributed share stays visible.
Currency breakdown
- USD 100.0 %
The quoted currency of each line, as declared.
Country breakdown
- United States 95.8 %
- Singapore 4.2 %
Shares computed on the equity sleeve.
| Rank | Country | Lines | Value | Share |
|---|---|---|---|---|
| 1 | United States | 38 | 91.7M $ | 95.79 % |
| 2 | Singapore | 1 | 4M $ | 4.21 % |
Cite this page
Titelia. "Holdings of F/m Emerald Life Sciences Innovation ETF". https://titelia.com/en/funds/S000088167